WEDNESDAY, SEPTEMBER 28, 2016

New vaccine targets meningitis A in Africa

New vaccine aims to eliminate meningitis A from Africa | Courtesy of myvmc.org
A new, affordable and effective vaccine designed to protect people from meningococcal A meningitis is targeting elimination of the virus in Africa.

Introduced just five years ago, the vaccine has almost eliminated meningitis A in Africa. There were just four laboratory-confirmed meningitis cases in the region in 2013.

“We have nearly eliminated meningitis A epidemics from Africa, but the fact is the job is not yet done,” Jean-Marie Okwo-Bele, the World Health Organization's director of immunization, vaccines and biologicals, said. “Our dramatic gains against meningitis A through mass vaccination campaigns will be jeopardized unless countries maintain a high level of protection by incorporating the meningitis A vaccine into their routine childhood immunization schedules.”

The disease is caused by a bacterial infection that infects the spinal cord and brain. The illness has infected people living in 26 different countries in sub-Saharan Africa for the last 100 years. It kills and disables people each year, particularly the young. Within hours, it can cause either death or severe brain damage.

“Countries now need to decide how best to sustain the protection that initial mass vaccination campaigns provided,” Marie-Pierre Preziosi, a member of the team that developed the vaccine, said. “Our experience from other vaccine-preventable diseases has shown that if we let our guard down, these diseases will severely rebound.”

Organizations in this story

World Health Organization 20 Avenue Appia Geneva, GE 01202

Get notified the next time we write about World Health Organization!